Tamoxifen therapy in unresectable adenocarcinoma of the pancreas
- PMID: 3038316
Tamoxifen therapy in unresectable adenocarcinoma of the pancreas
Abstract
Twenty-four patients with biopsy-documented unresectable ductal adenocarcinoma of the pancreas were treated with tamoxifen. Six of 15 postmenopausal female patients had documented prolonged survival, with three living greater than 2 years.
Similar articles
-
Survival benefit of tamoxifen therapy in adenocarcinoma of pancreas. A case-control study.Cancer. 1993 Apr 1;71(7):2200-3. doi: 10.1002/1097-0142(19930401)71:7<2200::aid-cncr2820710706>3.0.co;2-2. Cancer. 1993. PMID: 8384066
-
Adenocarcinoma of the pancreas--a hormone sensitive tumor? A preliminary report on Nolvadex treatment.Clin Oncol. 1983 Sep;9(3):193-7. Clin Oncol. 1983. PMID: 6616993 Clinical Trial.
-
The beneficial effect of tamoxifen therapy in patients with resected adenocarcinoma of the pancreas.Hepatogastroenterology. 1996 Sep-Oct;43(11):1225-9. Hepatogastroenterology. 1996. PMID: 8908555
-
Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.Surg Oncol Clin N Am. 2004 Oct;13(4):685-96, x. doi: 10.1016/j.soc.2004.06.013. Surg Oncol Clin N Am. 2004. PMID: 15350942 Review.
-
Adjuvant therapy following resection for pancreatic adenocarcinoma.Surg Oncol Clin N Am. 2004 Oct;13(4):555-66, vii. doi: 10.1016/j.soc.2004.06.008. Surg Oncol Clin N Am. 2004. PMID: 15350934 Review.
Cited by
-
R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers.BMC Cancer. 2020 Jun 8;20(1):531. doi: 10.1186/s12885-020-07005-x. BMC Cancer. 2020. PMID: 32513126 Free PMC article.
-
Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.Drugs. 1989 Apr;37(4):451-90. doi: 10.2165/00003495-198937040-00004. Drugs. 1989. PMID: 2661195 Review.
-
Chemoprevention for pancreatic cancer.Int J Gastrointest Cancer. 2003;33(1):27-41. doi: 10.1385/IJGC:33:1:27. Int J Gastrointest Cancer. 2003. PMID: 12909736 Review.
-
A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC).Transl Gastroenterol Hepatol. 2021 Jan 5;6:9. doi: 10.21037/tgh.2020.02.16. eCollection 2021. Transl Gastroenterol Hepatol. 2021. PMID: 33409403 Free PMC article.
-
Effects of sex steroid hormones on pancreatic cancer in the rat.Int J Pancreatol. 1990 Aug-Nov;7(1-3):159-65. doi: 10.1007/BF02924233. Int J Pancreatol. 1990. PMID: 2081921
MeSH terms
Substances
LinkOut - more resources
Medical